Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Guha
Abhijit Guha, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20100255514 | TUMOR CELL-DERIVED MICROVESICLES - The present invention relates to a method for diagnosis of cancer and for monitoring the progression of cancer and/or the therapeutic efficacy of an anti-cancer treatment in a sample of a subject by detecting oncogenic and cancer related proteins in microvesicles, and to the use of an agent blocking exchange of microvesicles for treating cancer. | 10-07-2010 |
Ashish Guha, Maharashtra IN
| Patent application number | Description | Published |
|---|---|---|
| 20110005960 | STABLE PHARMACEUTICAL COMPOSITIONS OF CARVEDILOL - A stable solid oral pharmaceutical composition comprising carvedilol or a pharmaceutically acceptable salt thereof, which is packed using a suitable packaging material along with a desiccant. A process for manufacturing a stable solid oral dosage form containing carvedilol or a pharmaceutically acceptable salt thereof, which is packed in the packaging configuration comprising moisture permeation inhibitory packaging. A method of preparing a stable solid oral pharmaceutical dosage form, said method comprising, encasing a pharmaceutical dosage form comprising carvedilol or pharmaceutically acceptable salt thereof in a container comprising a desiccant. A pharmaceutical kit comprising a container impervious to moisture, wherein said container comprises a desiccant; and a solid oral pharmaceutical dosage form comprising carvedilol or a pharmaceutically acceptable salt thereof, wherein said pharmaceutical dosage form is encased in said container. | 01-13-2011 |
Rabindra Guha, Stittsville CA
| Patent application number | Description | Published |
|---|---|---|
| 20080198170 | SYSTEM AND METHOD FOR DMA CONTROLLED IMAGE PROCESSING - A system for processing image data from a plurality of images is disclosed. The invention involves alpha blending of two images of different resolution and color space utilizing shared logic for multiple image streams and without display storage frame buffer. The invention utilizes Direct Memory Access (DMA) fetching module for fetching image data from source images or from source image memory areas and transferring the data to another memory area without having to go through a central processing unit or display storage frame buffer. The DMAs are configured with direct registers or memory mapped descriptors as to the location of the source data. The DMA channels of the DMA module will fetch a portion of the source images (tiling) utilizing a link list or series of descriptors in a certain fetching order. The DMA modules can perform the alpha blending on the fetched image data. | 08-21-2008 |
Saikat Guha, Kaiserslautern DE
| Patent application number | Description | Published |
|---|---|---|
| 20110055552 | PRIVATE, ACCOUNTABLE, AND PERSONALIZED INFORMATION DELIVERY IN A NETWORKED SYSTEM - A client receives a notification of a user interaction with an information item and creates a record describing this interaction. The client encrypts the record using an encryption key associated with a server. The encrypted record is then communicated to at least one proxy, which in turn forwards the encrypted record to a server. Upon receiving the encrypted record from the proxy, a server decrypts the record using a decryption key and analyzes the decrypted record to identify the information item and the type of user interaction. This information may be used individually or in aggregate for tracking user interests, billing advertisers or information item providers, and/or collecting anonymous information from users. | 03-03-2011 |
Saikat Guha, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20110252226 | PRESERVING USER PRIVACY IN RESPONSE TO USER INTERACTIONS - User privacy is preserved in response to user interactions with information items, such as advertisements, by controlling the behavior of a user's computer. Information items are associated with item response specifiers. Item response specifiers control the behaviors of the user's computer in response to user interactions with information items. Item response specifiers may be communicated to the user's computer with the associated information items or be retrieved separately by the user's computer from an information item broker or trusted third party. Item response specifiers may be cryptographically signed to ensure their integrity. Following a user interaction with an information item, the user's computer refers to the item response specifier to determine an appropriate privacy-preserving post-interaction behavior. Examples of privacy-preserving behavior include a silent privacy-preserving behavior, a proxied interaction privacy-preserving behavior, a partial proxied interaction privacy-preserving behavior, a delayed handoff privacy-preserving behavior, and a direct to provider privacy-preserving behavior. | 10-13-2011 |
Samar Kumar Guha, Kunggi-Do KR
| Patent application number | Description | Published |
|---|---|---|
| 20080262271 | C10 Dialdehyde, Synthetic Method Thereof, and Synthetic Method of Beta-Carotene Using the Same - The novel intermediate compound which can be efficiently utilized in the synthesis of carotenoid compounds based on the sulfone chemistry, the preparation method of the same, and the practical synthetic process for preparing β-carotene by the use of the above novel compound are disclosed. The synthesis of β-carotene is characterized by the double elimination reactions of the C | 10-23-2008 |
Sujoy Kumar Guha, New Dehli IN
| Patent application number | Description | Published |
|---|---|---|
| 20110002979 | STYRENE MALEIC ANHYDRIDE BASED FORMULATION FOR MALE CONTRACEPTION AND PROSTATE CANCER - The invention provides a styrene maleic anhydride based synergistic formulation comprising styrene maleic anhydride [SMA] having lower molecular weight and styrene maleic anhydride [SMA] having higher molecular weight dissolved in DMSO, and being capable of preventing the prostate cancer as well as causing male contraception even when administered in smaller doses for one or two administrations in the life time and predominantly causing no or minimal side effects, and still being reasonably affordable by common man, and the formulation being capable of traveling along the vas deferens after causing male contraception in the vas deferens to the prostate gland and getting absorbed into the epithelial zone of the prostate gland. | 01-06-2011 |